Gunnar F. Kaufmann - 12 Jun 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Scientific Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
ONCT
Transactions as of
12 Jun 2023
Transactions value $
$9,824
Form type
4
Filing time
14 Jun 2023, 16:00:26 UTC
Previous filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $8.75K +25K +37.47% $0.35 91.7K 12 Jun 2023 Direct F1
transaction ONCT Common Stock Purchase $1.08K +3K +3.27% $0.36 94.7K 14 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.3448 to $0.3500. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.